WallStSmart

GoHealth Inc. (GOCO)vsMarsh & McLennan Companies, Inc. (MRSH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies, Inc. generates 17910% more annual revenue ($27.52B vs $152.79M). MRSH leads profitability with a 14.3% profit margin vs -189.7%. MRSH earns a higher WallStSmart Score of 58/100 (C).

GOCO

Avoid

33

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -1.81

MRSH

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 7.5Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.74

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GOCO1 strengths · Avg: 10.0/10
EPS GrowthGrowth
424.1%10/10

Earnings expanding 424.1% YoY

MRSH3 strengths · Avg: 8.7/10
Market CapQuality
$79.75B9/10

Large-cap with strong market position

Return on EquityProfitability
26.9%9/10

Every $100 of equity generates 27 in profit

Operating MarginProfitability
24.3%8/10

Strong operational efficiency at 24.3%

Areas to Watch

GOCO4 concerns · Avg: 2.5/10
Market CapQuality
$19.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-219.7%2/10

ROE of -219.7% — below average capital efficiency

Revenue GrowthGrowth
-94.6%2/10

Revenue declined 94.6%

MRSH4 concerns · Avg: 3.3/10
PEG RatioValuation
1.624/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Debt/EquityHealth
1.543/10

Elevated debt levels

EPS GrowthGrowth
-15.4%2/10

Earnings declined 15.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : GOCO

The strongest argument for GOCO centers on EPS Growth.

Bull Case : MRSH

The strongest argument for MRSH centers on Market Cap, Return on Equity, Operating Margin.

Bear Case : GOCO

The primary concerns for GOCO are Market Cap, Piotroski F-Score, Return on Equity. Debt-to-equity of 350.08 is elevated, increasing financial risk.

Bear Case : MRSH

The primary concerns for MRSH are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 1.54 is elevated, increasing financial risk.

Key Dynamics to Monitor

GOCO profiles as a turnaround stock while MRSH is a value play — different risk/reward profiles.

GOCO carries more volatility with a beta of 1.17 — expect wider price swings.

MRSH is growing revenue faster at 7.6% — sustainability is the question.

GOCO generates stronger free cash flow (7M), providing more financial flexibility.

Bottom Line

MRSH scores higher overall (58/100 vs 33/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GoHealth Inc.

FINANCIAL SERVICES · INSURANCE BROKERS · USA

GoHealth, Inc. is a health insurance marketplace and a Medicare-focused digital health company in the United States. The company is headquartered in Chicago, Illinois.

Marsh & McLennan Companies, Inc.

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?